PodParley PodParley

How real-time data could transform clinical trials

Episode 31 of the The Pharma Letter Podcast podcast, hosted by With Yonalink CEO and co-founder Iddo Peleg, titled "How real-time data could transform clinical trials" was published on March 11, 2025 and runs 15 minutes.

March 11, 2025 ·15m · The Pharma Letter Podcast

0:00 / 0:00

In this week’s podcast, we welcome Iddo Peleg, CEO and co-founder of Yonalink, who provides insights into the current and future state of the clinical trial industry. As we move headlong into 2025, a year that appears set to be characterized by global economic and political turmoil, Iddo discusses major trends in the industry, including challenges posed by the COVID-19 aftermath and the potential impacts of regulatory upheaval on clinical trials. He also outlines how Yonalink’s ...

In this week’s podcast, we welcome Iddo Peleg, CEO and co-founder of Yonalink, who provides insights into the current and future state of the clinical trial industry. 

As we move headlong into 2025, a year that appears set to be characterized by global economic and political turmoil, Iddo discusses major trends in the industry, including challenges posed by the COVID-19 aftermath and the potential impacts of regulatory upheaval on clinical trials. 

He also outlines how Yonalink’s technology, which streams data from electronic health records to clinical trial databases, can dramatically reduce timelines and improve accuracy in clinical studies. 

The conversation delves into the practicalities and potentials of decentralized and distributed clinical trials, offering advice to young biotech startups on leveraging the right technology for innovation.

The Pharmadelic Experience The Pharmadelic Experience The Pharmadelic Experience podcast explores career opportunities in the pharma sector. Each episode will focus on a different career field, so you can learn what they do, how they got there and what challenges they have encountered along the way. For inquiries email: [email protected] Deep Pharma Intelligence Deep Pharma Intelligence Deep Pharma Intelligence (DPI) is a leading strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, BioTech, and Healthcare Tech industries. DPI is producing regular analytical reports on major areas of high-potential in the pharmaceutical and healthcare industries, maintaining ratings of companies and governments based on their innovation potential and business activity in the BioTech space, and providing strategic consulting and investment intelligence services to top-tier clients. Organik Blonde Organik Blonde Welcome to the Organik Blonde podcast where I share the trials and tribulations of converting to more plant based living. Raising three kids on my own and unlearning societies tricks into sugar, plastics and big pharma. Conscientious Living Made Easy 🥑 🌏🐝www.innerorigin.com/organikblonde @organikblonde Opening Bell: Pre market briefings Opening Bell: Pre-market briefings Disclaimer: Only for educational purpose ; we do not recommend or advocate any stocks mentioned during the call. Sources Investing.com / moneycontrol.com / Bloomberg / Business Standard / ET /Mint / BSE / Financial Express/ Hindu Business Line /# world pharma news , # express pharma news# pharmabiz# medical dialogues# economic times# fierce pharma# pharma times# pharma tutor# CNBCTV18# money control# asset multiplier# institute of health metrics & evaluation;#BSE filings#India chemical news#India chemical weekly#equitybulls.com
URL copied to clipboard!